Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Type 2 Diabetes
NCT00451620Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Nov 2003
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by University of British Columbia. Started Nov 2003; status: completed.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00451620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451620.